EOS imaging received approval from the China Food and Drug Administration to market the EOS orthopaedic imaging system in China.
The clearance falls in line with the company’s strategy to expand in North America, the EU, Middle East and Asia Pacific. EOS cites >1,200 top grade (3A and 3B) hospitals in China within an already-established distribution partnership.
EOS imaging received approval from the China Food and Drug Administration to market the EOS orthopaedic imaging system in China.
The clearance falls in line with the company's strategy to expand in North America, the EU, Middle East and Asia Pacific. EOS cites >1,200 top grade (3A and 3B) hospitals in China within an already-established...
EOS imaging received approval from the China Food and Drug Administration to market the EOS orthopaedic imaging system in China.
The clearance falls in line with the company’s strategy to expand in North America, the EU, Middle East and Asia Pacific. EOS cites >1,200 top grade (3A and 3B) hospitals in China within an already-established distribution partnership.
Copy to clipboard 
